Last reviewed · How we verify
COLESEVELAM HYDROCHLORIDE
COLESEVELAM HYDROCHLORIDE is a drug. It is currently FDA-approved (first approved 2000).
At a glance
| Generic name | COLESEVELAM HYDROCHLORIDE |
|---|---|
| Phase | FDA-approved |
| First approval | 2000 |
Approved indications
Common side effects
- Constipation
- Dyspepsia
- Nausea
- Headache
- Nasopharyngitis
- Upper respiratory tract infection
- Influenza
- Abdominal pain
Serious adverse events
- Hypersensitivity reaction (body rash and mouth blistering)
Key clinical trials
- Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE) (PHASE1, PHASE2)
- A Study of Colesevelam for Lenalidomide-Associated Diarrhea (PHASE2)
- Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
- Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery (EARLY_PHASE1)
- Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib (PHASE2)
- Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation. (PHASE1, PHASE2)
- A Study of Colesevelam in Fecal Incontinence (PHASE3)
- Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- COLESEVELAM HYDROCHLORIDE CI brief — competitive landscape report
- COLESEVELAM HYDROCHLORIDE updates RSS · CI watch RSS
Frequently asked questions about COLESEVELAM HYDROCHLORIDE
What is COLESEVELAM HYDROCHLORIDE?
COLESEVELAM HYDROCHLORIDE is a pharmaceutical drug.
When was COLESEVELAM HYDROCHLORIDE approved?
COLESEVELAM HYDROCHLORIDE was first approved on 2000.
What development phase is COLESEVELAM HYDROCHLORIDE in?
COLESEVELAM HYDROCHLORIDE is FDA-approved (marketed).
What are the side effects of COLESEVELAM HYDROCHLORIDE?
Common side effects of COLESEVELAM HYDROCHLORIDE include Constipation, Dyspepsia, Nausea, Headache, Nasopharyngitis, Upper respiratory tract infection. Serious adverse events: Hypersensitivity reaction (body rash and mouth blistering).